Małecki et al. determine that the lack of EGFR expression instead of p53 and Ki-67 is a favorable predictor for IC response in patients with advanced hypopharyngeal cancer who are treated with a larynx-preservation treatment (17). The gene discussed is MKI67; the disease is hypopharynx cancer.